MovDisordV3, France, Analysis, indexItem, Author.i, Peter Jenner

Peter Hagell < Peter Jenner < Peter Lantos

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000064 (2013)	Etienne C. Hirsch [France] ; Peter Jenner ; Serge Przedborski	Pathogenesis of Parkinson's disease.
000432 (2004)	C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]	Levodopa in the treatment of Parkinson's disease: Current controversies
000468 (2002)	Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation
000587 (1997)	G. Fénelon [France] ; G. Percheron [France] ; Joseph Jankovic [États-Unis] ; Manfred Gerlach [Allemagne] ; Kay Double [Allemagne] ; Peter Riederer [Allemagne] ; Etienne Hirsch [France] ; Kurt Jellinger [Autriche] ; Peter Jenner [Royaume-Uni] ; Alfred Trautwein [Allemagne] ; Moussa B. H. Youdim [Israël] ; Andrzej Friedman [Pologne] ; J. Galazka-Friedman [Pologne] ; E. R. Bauminger [Israël] ; D. Hechel [Israël] ; I. Nowik [Israël] ; M. Barcikowska [Pologne] ; M. Nomoto [Japon] ; S. Kaseda [Japon] ; S. Iwata [Japon] ; M. Osame [Argentine] ; T. Fukuda [Japon] ; Federico Micheli [Argentine] ; María Clara Scorticati [Argentine] ; Pratap Chand [Oman] ; P. C. Jacob [Oman]	Letter to the editor

List of associated KwdEn.i

Nombre de documents	Descripteur
3	Humans
2	Antiparkinson Agents (adverse effects)
2	Antiparkinson Agents (therapeutic use)
2	Corpus Striatum (metabolism)
2	Dyskinesia, Drug-Induced (etiology)
2	Levodopa
2	Levodopa (adverse effects)
2	Parkinson disease
2	Parkinson's disease
2	Treatment
2	dyskinesia
1	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
1	Agonist
1	Animal
1	Animals
1	Antiparkinson Agents (administration & dosage)
1	Antiparkinson Agents (pharmacokinetics)
1	Antiparkinson agent
1	Arousal (drug effects)
1	Basal Ganglia Diseases (classification)
1	Basal Ganglia Diseases (diagnosis)
1	Calcium (metabolism)
1	Callithrix
1	Caudate Nucleus (metabolism)
1	Cell Death (physiology)
1	Chemotherapy
1	Comparative study
1	Corpus Striatum (drug effects)
1	Culture Techniques
1	Diagnosis, Differential
1	Dopamine receptor
1	Drug Administration Schedule
1	Dyskinesia
1	Dyskinesias (diagnosis)
1	Dyskinesias (drug therapy)
1	Dyskinesias (metabolism)
1	Experimental disease
1	Female
1	In Situ Hybridization
1	Levodopa (pharmacokinetics)
1	Levodopa (therapeutic use)
1	Locomotion (drug effects)
1	MPTP‐treated primates
1	Male
1	Mitochondrial Diseases (complications)
1	Monkey
1	Movement Disorders (classification)
1	Movement Disorders (diagnosis)
1	Nerve Degeneration (pathology)
1	Nervous system diseases
1	Neurons (metabolism)
1	Neurons (pathology)
1	Parkinson Disease (drug therapy)
1	Parkinson Disease (etiology)
1	Parkinson Disease (pathology)
1	Piribedil
1	Piribedil (administration & dosage)
1	Piribedil (adverse effects)
1	Piribedil (therapeutic use)
1	RNA, Messenger (metabolism)
1	Receptors, Dopamine (drug effects)
1	Receptors, Dopamine (metabolism)
1	Severity of Illness Index
1	Terminology as Topic
1	Time Factors
1	levodopa
1	locomotor activity
1	motor complications
1	neurotoxicity
1	piribedil
1	vigilance

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Peter Jenner"

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Peter Jenner" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Peter Jenner
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue) - Analysis (France) Index « Auteurs » - entrée « Peter Jenner »
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue) - Analysis (France)Index « Auteurs » - entrée « Peter Jenner »

List of bibliographic references

List of associated KwdEn.i

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Peter Jenner »